Tobias Gerhard is a Professor of Pharmacy and Epidemiology at Rutgers University. He is Director of the Rutgers Institute for Health, Health Care Policy and Aging Research and Founding Director of its Center for Pharmacoepidemiology and Treatment Science (through August 2025). His work focuses on the development and evaluation of modern pharmacoepidemiologic methods with applications in mental health and geriatric pharmacotherapy. He has published widely on use, safety, and outcomes of therapeutics, particularly of psychotropic medications in vulnerable populations. His research has been funded by NIA, NIMH, AHRQ, PCORI, and by multiple foundations. Dr. Gerhard’s work has been recognized with a Young Investigator Award from the Brain and Behavior Research Foundation, a New Investigator Award from the American Society of Clinical Psychopharmacology, and the 2020 Sternfels Prize for Drug Safety Discoveries. Dr. Gerhard is a Fellow and Past President of the International Society for Pharmacoepidemiology (ISPE) and an elected member of the American Epidemiological Society (AES). He has served on committees for the Food and Drug Administration (FDA) and the National Academies of Sciences, Engineering, and Medicine (NASEM).